Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Clinical trial NCT01534637 · COMPLETED

Trial details

NCT number: NCT01534637
Sponsor: Wake Forest University Health Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Extrahepatic Bile Duct Cancer Nausea Vomiting Stage II Pancreatic Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer

Start date: 2006-08-01
Primary completion: 2009-12-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.